Targeting the JAK-STAT Pathway in AD : vimarsana.com

Alexandra Golant, MD; Christopher Bunick, MD, PhD; and Peter Lio, MD, comment on how targeting the JAK-STAT (signal transducer and activator of transcription) pathway with JAK inhibitors plays a role in managing AD.

Related Keywords

Lisa Swanson , Alexandra Golant , Christopher Bunick , , Peter Lio , Jak Stat Pathway , Atopic Dermatitis , Inhibition Of Cytokine Signaling , Th11 ,